Transaction and compliance framework
Understand seller eligibility, WDA and GDP verification boundaries, and the separate roles of the PharmaBatch platform and River Pharma GmbH in proposed transactions.
Seller eligibility
Seller access is deliberately narrower than buyer access. Only eligible legal entities established in the EU-27 may apply, and approval remains subject to organisation, authorisation and official-record review.
Can search exact packs, request listed stock and publish RFQs. A buyer account cannot list batches or respond to RFQs as a seller.
Includes all buyer tools, plus the ability to submit lots and answer buyer RFQs after seller-level approval.
Eligible seller jurisdiction
Eligibility follows the seller legal entity’s registered country—not the medicine’s origin. Approval is never automatic.
Wholesale distributors are authorised and inspected by the relevant national competent authority against EU GDP requirements. EudraGMDP, the official database operated by EMA, is a critical verification layer for WDA, GDP certificate and non-compliance records. EMA operates the database and coordinates EU-level GDP activity; it does not itself issue every national WDA.
Transaction process
Each stage has a clear owner. A marketplace match becomes a wholesale transaction only after River Pharma GmbH accepts it.
Buyer applicants request buying-only access. Only eligible EU-27 legal entities may request verified seller access, which includes buying and selling. Marketplace tools open only after application review.
A buyer creates an RFQ or an approved supplier presents available stock against the correct private medicine record.
Each participant reviews the exact pack, quantity, price applicable to its side, origin, expiry, destination and other stated conditions. Supplier net prices and buyer final product prices are kept separate and confidential.
The selected proposal is passed to River Pharma GmbH for its own transaction and documentation review.
If River Pharma GmbH accepts the transaction, it confirms the applicable terms and issues the commercial medicine invoice to the buyer.
The seller follows the accepted purchase and fulfilment instructions. Settlement and the marketplace status record follow the agreed transaction terms.
Invoice and settlement
For an accepted wholesale transaction, the commercial medicine invoice does not come from PharmaBatch.
The buyer receives and pays the commercial medicine invoice issued by River Pharma GmbH.
Wholesale contracting and commercial medicine-invoicing party for an accepted transaction.
The supplier receives the applicable purchasing instructions and settlement from River Pharma GmbH based on the supplier net price and the accepted transaction terms.
PharmaBatch supplies the marketplace technology and transaction workflow. The buyer-facing final product price includes the 6.5% marketplace fee. Any transaction-specific logistics or other separately chargeable service is manually itemised in the applicable commercial documents and invoice.
Tell us whether your organisation needs buying-only or verified seller access, and which part of the transaction process you need clarified.
Contact PharmaBatch